Samsung Bioepis Co., Ltd.
三星Bioepis
Licensing announcements since 2025
| Date | Counterparty | Asset / platform | Upfront | Near-term | Potential total | Stage at announcement |
|---|---|---|---|---|---|---|
| 2026-06-18 | Organon | PYZCHIVA / ustekinumab biosimilar | Not disclosed | Not disclosed | Not disclosed | Commercialization agreement for Canada |